8 mg bottle (30 count)
Indication: Buprenorphine sublingual tablet, contains buprenorphine, a partial opioid agonist, and is indicated for the treatment of opioid dependence and is preferred for induction.
Buprenorphine sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support.
Please see full Prescribing Information for more information.
Markings: Uncoated, round, biconvex, white to off-white, sublingual tablets, debossed with ‘460’ on one side and plain on other side.
Storage and Handling: Store at 20° to 25°C (68° to 77°F).